Deerfield Management Company, L.P. (Series C) Pulmonx Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Pulmonx Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,890,000 shares of LUNG stock, worth $3.01 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,890,000
Previous 1,890,000
-0.0%
Holding current value
$3.01 Million
Previous $12.7 Million
61.51%
% of portfolio
0.11%
Previous 0.32%
Shares
15 transactions
Others Institutions Holding LUNG
# of Institutions
120Shares Held
33.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA5.16MShares$8.21 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$5.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.65 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$1.91 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $59.3M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...